Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Pisit Pitukcheewanont"'
Autor:
Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/1583f1afe5a54ea596b4387156690961
Autor:
Peter Kamenický, Anthony A. Portale, Tom Carpenter, Karine Briot, Erik A. Imel, Thomas Weber, Pisit Pitukcheewanont, Hae Il Cheong, Suzanne Jan de Beur, Yasuo Imanishi, Nobuaki Ito, Robin Lachmann, Hiroyuki Tanaka, Farzana Perwad, Lin Zhang, Alison Skrinar, Linda Rees, Karl L. Insogna
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100654- (2020)
Externí odkaz:
https://doaj.org/article/8231e2f3c59e4b729a9ca6cb8b3de4dc
Publikováno v:
Case Reports in Otolaryngology, Vol 2013 (2013)
Externí odkaz:
https://doaj.org/article/e4fd4e16134443788297b7c510975cd1
Autor:
Anna Ryabets-Lienhard, Panadeekarn Panjawatanan, Kyle Vogt, Jianling Ji, Senta Georgia, Pisit Pitukcheewanont
Publikováno v:
Calcified Tissue International. 112:518-523
Progressive osseous heteroplasia (POH) is a rare, debilitating disorder characterized by heterotopic ossification in the skin and muscles, resulting in contractures of the joints and progressive loss of function. While 60-70% of the POH patients have
Autor:
Maria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, Thomas Carpenter, Hae Il Cheong, Martine Cohen-Solal, Rachel K. Crowley, Richard Eastell, Yasuo Imanishi, Erik A. Imel, Steven W. Ing, Karl Insogna, Nobuaki Ito, Kassim Javaid, Peter Kamenicky, Richard Keen, Takuo Kubota, Robin H. Lachmann, Farzana Perwad, Pisit Pitukcheewanont, Anthony Portale, Stuart H. Ralston, Hiroyuki Tanaka, Thomas J. Weber, Han-Wook Yoo, Wei Sun, Angela Williams, Annabel Nixon, Yasuhiro Takeuchi
Publikováno v:
Calcified Tissue International. 111:409-418
The anti-fibroblast growth factor 23 monoclonal antibody burosumab corrects hypophosphatemia in adults with X-linked hypophosphatemia (XLH) and improves pain, stiffness, physical function, and fatigue. This post hoc subgroup analysis used data from t
Autor:
Imel, Erik A., Glorieux, Francis H., Whyte, Michael P., Portale, Anthony A., Munns, Craig F., Nilsson, Ola, Simmons, Jill H., Padidela, Raja, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Sochett, Etienne, Högler, Wolfgang, Koji Muroya, Hiroyuki Tanaka, Gottesman, Gary S., Biggin, Andrew, Perwad, Farzana, Chen, Angel, Roberts, Mary Scott
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; Nov2023, Vol. 108 Issue 11, p2990-2998, 9p
Autor:
Erik A Imel, Francis H Glorieux, Michael P Whyte, Anthony A Portale, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, Mary Scott Roberts, Leanne M Ward
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context In an open-label, randomized, controlled, phase 3 trial in 61 children aged 1 to 12 years with X-linked hypophosphatemia (XLH), burosumab improved rickets vs continuing conventional therapy with active vitamin D and phosphate. Objective We co
Autor:
Thomas Weber, Karl L. Insogna, Stuart H. Ralston, Farzana Perwad, Erik A. Imel, Mark Nixon, Hae Ii Cheong, Richard Eastell, Nobuaki Ito, Robin H. Lachmann, Suzanne M. Jan de Beur, Yasuo Imanishi, Angela Williams, Martine Cohen-Solal, Peter Kamenicky, Wei Sun, Annabel Nixon, Pisit Pitukcheewanont, Anthony A. Portale, Thomas O. Carpenter, Muhammad Javaid, Karine Briot, Hiroyuki Tanaka, Maria Luisa Brandi, Steven W. Ing, Rachel K Crowley, Takuo Kubota, Han Wook Yoo, Richard Keen, Yasuhiro Takeuchi
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
RMD Open
RMD Open
ObjectivesTo report the impact of burosumab on patient-reported outcomes (PROs) and ambulatory function in adults with X-linked hypophosphataemia (XLH) through 96 weeks.MethodsAdults diagnosed with XLH were randomised 1:1 in a double-blinded trial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cd553f48f41260bba3c6ca756adb47
https://eprints.whiterose.ac.uk/178786/1/e001714.full.pdf
https://eprints.whiterose.ac.uk/178786/1/e001714.full.pdf
Autor:
Anna Ryabets-Lienhard, Senta Georgia, Robert Olney, Sara Akhtar Ali, Leigh Ramos-Platt, Pisit Pitukcheewanont, Harsimar Kang
Publikováno v:
Bone. 127:215-219
Background There have been new advances in understanding bone remodeling on a molecular level including the RANKL-OPG pathway, leading to advancements in targeted therapeutic intervention. There is however limited data in pediatrics with little known
Autor:
Hae Il Cheong, Meng Mao, Ola Nilsson, Alison Skrinar, Gary S. Gottesman, Wolfgang Högler, Javier San Martin, Hiroyuki Tanaka, Noriyuki Namba, Raja Padidela, Francis H. Glorieux, Michael P. Whyte, Koji Muroya, Craig F Munns, Chao-Yin Chen, Andrew Biggin, Erik A. Imel, Etienne Sochett, Leanne Ward, Anthony A. Portale, Jill H. Simmons, Farzana Perwad, Pisit Pitukcheewanont
Publikováno v:
The Lancet. 393:2416-2427
X-linked hypophosphataemia in children is characterised by elevated serum concentrations of fibroblast growth factor 23 (FGF23), hypophosphataemia, rickets, lower extremity bowing, and growth impairment. We compared the efficacy and safety of continu